179045-86-4 basiliximab
Nazwa produktu: |
basiliximab |
Angielska nazwa |
basiliximab;Basiliximab [USAN]; Basiliximab; Immunoglobulin G 1 (human-mouse monoclonal CHI621 heavy chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal CHI621 light chain, dimer; Immunoglobulin G1 (human-mouse monoclonal CHI621 heavy chain antihuman interleukin 2 receptor), disulfide with human-mouse monoclonal CHI621 light chain, dimer; Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 gamma1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer; SDZ-CHI-621; Simulect; UNII-9927MT646M; Immunoglobulin G1, anti-(human interleukin 2 receptor)(human-mouse monoclonal CHI621 gamma1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer |
Nr CAS |
179045-86-4 |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|